# Guardant Health (GH) — Earnings

GH · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/gh/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.90 |
| EPS estimate | −$0.76 |
| EPS surprise | −18.14% |
| Revenue surprise | +6.60% |
| Revenue | $335.0M |
| Revenue estimate | $314.2M |
| Reported | Jul 30, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1576280/000157628026000037/gh-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/944b3406-8fa9-1a4e-32c4-d14494dd2581.html) |

Guardant Health reported Q2 2026 results on July 30, 2026. It posted a loss of $0.90 per share, wider than the expected loss of $0.76, an 18.14% miss. Revenue was $335.0 million, beating the $314.2 million estimate by 6.60%. Compared with Q2 2025, the loss per share widened from $0.80, while revenue grew about 44% from $232.1 million.

Every quarter in the table is a loss. Annual losses narrowed from $6.40 per share in 2022 to $4.28 in 2023, $3.56 in 2024 and $3.31 in 2025. The first half of 2026 shows a loss of $1.75 per share, against $1.57 a year earlier. Revenue has grown steadily, from $94.8 million in Q3 2021 to the latest quarter's $335.0 million, the highest in the table, and it topped the revenue estimate in 19 of 20 quarters. On earnings, it beat the estimate 8 times and missed it 12 times over the same 20 quarters.

The company reported its third quarter between October 29 and November 6 in each of the past five years. That points to late October or early November 2026 for the Q3 2026 report. It will show how the quarterly loss compares with $0.74 in Q3 2025.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 30, 2026 | −$0.76 | −$0.90 | -18.14% | $314.2M | $335.0M |
| Q1 2026 | May 7, 2026 | −$0.81 | −$0.85 | -5.46% | $279.2M | $301.7M |
| Q4 2025 | Feb 19, 2026 | −$0.77 | −$1.00 | -30.41% | $272.4M | $281.3M |
| Q3 2025 | Oct 29, 2025 | −$0.79 | −$0.74 | 6.28% | $235.6M | $265.2M |
| Q2 2025 | Jul 30, 2025 | −$0.74 | −$0.80 | -8.04% | $211.5M | $232.1M |
| Q1 2025 | Apr 30, 2025 | −$0.79 | −$0.77 | 2.00% | $190.1M | $203.5M |
| Q4 2024 | Feb 20, 2025 | −$0.78 | −$0.90 | -15.80% | $192.1M | $201.8M |
| Q3 2024 | Nov 6, 2024 | −$0.73 | −$0.88 | -20.48% | $170.5M | $191.5M |
| Q2 2024 | Aug 7, 2024 | −$0.75 | −$0.84 | -11.48% | $162.6M | $177.2M |
| Q1 2024 | May 9, 2024 | −$0.88 | −$0.94 | -6.92% | $150.1M | $168.5M |
| Q4 2023 | Feb 22, 2024 | −$0.86 | −$1.58 | -83.27% | $149.6M | $155.1M |
| Q3 2023 | Nov 6, 2023 | −$0.97 | −$0.73 | 24.55% | $137.3M | $143.0M |
| Q2 2023 | Aug 3, 2023 | −$1.22 | −$0.67 | 44.96% | $129.8M | $137.2M |
| Q1 2023 | May 9, 2023 | −$1.34 | −$1.30 | 2.82% | $117.9M | $128.7M |
| Q4 2022 | Feb 23, 2023 | −$1.40 | −$1.36 | 2.95% | $123.8M | $126.9M |
| Q3 2022 | Nov 3, 2022 | −$1.28 | −$1.58 | -23.38% | $117.7M | $117.4M |
| Q2 2022 | Aug 4, 2022 | −$1.21 | −$2.25 | -85.32% | $105.1M | $109.1M |
| Q1 2022 | May 5, 2022 | −$1.21 | −$1.21 | 0.27% | $95.8M | $96.1M |
| Q4 2021 | Feb 23, 2022 | −$1.11 | −$0.89 | 19.70% | $98.6M | $108.1M |
| Q3 2021 | Nov 4, 2021 | −$0.88 | −$1.06 | -20.03% | $92.0M | $94.8M |

## Frequently Asked Questions

### When did Guardant Health (GH) last report earnings?

Guardant Health last reported on Jul 30, 2026, covering fiscal Q2 2026.

### Did GH beat earnings estimates?

No. Guardant Health reported EPS of −$0.90 for Q2 2026 against a −$0.76 estimate — a 18.14% miss.

### How much revenue did GH report last quarter?

Guardant Health reported $335.0M in revenue for Q2 2026, against a consensus estimate of $314.2M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).